Xueyuan Wang Selected Research

Xueyuan Wang Research Topics

Disease

18	Drug Resistant Epilepsy 09/2023 - 12/2017
14	Neoplasms (Cancer) 04/2024 - 02/2009
12	Epilepsy (Aura) 01/2024 - 12/2017
6	Multiple Myeloma 03/2023 - 01/2018
5	Seizures (Absence Seizure) 08/2021 - 12/2017
4	Triple Negative Breast Neoplasms 04/2024 - 01/2019
3	Partial Epilepsies (Epilepsy, Partial) 01/2023 - 01/2018
3	Breast Neoplasms (Breast Cancer) 04/2022 - 02/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 07/2017
2	Temporal Lobe Epilepsy 01/2018 - 01/2018
1	Dysbiosis 05/2024
1	Inflammation (Inflammations) 05/2024
1	Colitis 05/2024
1	Ulcerative Colitis 05/2024
1	Hypoxia (Hypoxemia) 04/2024
1	Starvation 04/2024
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 11/2022
1	Bone Resorption 11/2022
1	Periodontitis 11/2022
1	Pneumonia (Pneumonitis) 11/2022
1	Cognitive Dysfunction 04/2022
1	Brain Injuries (Brain Injury) 04/2022
1	Psychomotor Disorders 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Cardiotoxicity 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Hypertension (High Blood Pressure) 11/2011

Drug/Important Bio-Agent (IBA)

6	Proteasome InhibitorsIBA 03/2023 - 01/2018
3	Boronic AcidsIBA 03/2023 - 01/2018
3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 01/2019
2	CyclodextrinsIBA 04/2024 - 01/2023
2	lonidamineIBA 04/2024 - 01/2023
2	EnzymesIBA 04/2024 - 01/2022
2	tocophersolanIBA 01/2023 - 12/2019
2	Valosin Containing ProteinIBA 11/2022 - 01/2019
2	Anticonvulsants (Antiepileptic Drugs)IBA 08/2021 - 11/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2019 - 02/2019
1	Dextran SulfateIBA 05/2024
1	16S Ribosomal RNAIBA 05/2024
1	Galactose (Galactopyranose)FDA LinkGeneric 05/2024
1	Polysaccharides (Glycans)IBA 05/2024
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2024
1	Photosensitizing Agents (Photosensitizers)IBA 04/2024
1	Nanoparticle Drug Delivery SystemIBA 04/2024
1	phytochlorinIBA 04/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024
1	ProdrugsIBA 03/2023
1	DipeptidesIBA 03/2023
1	EstersIBA 03/2023
1	carboxymethyl-chitosanIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	triphenylphosphoniumIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	selinexorIBA 01/2023
1	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 01/2023
1	Glutathione (Reduced Glutathione)IBA 01/2023
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2023
1	Carrier Proteins (Binding Protein)IBA 01/2023
1	CytokinesIBA 11/2022
1	AnthracyclinesIBA 04/2022
1	Hydroxyl RadicalIBA 01/2022
1	CopperIBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	propylene oxideIBA 01/2021
1	carfilzomibIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	UbiquitinIBA 01/2021
1	PolylysineIBA 12/2019
1	polyethylene glycol 1000IBA 12/2019
1	Liposomes (Liposome)IBA 12/2019
1	Hyaluronic Acid (Hyaluronan)IBA 12/2019
1	Succinic Acid (Succinate)IBA 12/2019
1	Sorafenib (BAY 43-9006)FDA Link 12/2019
1	Deoxycholic Acid (Sodium Deoxycholate)IBA 12/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2019
1	Gemcitabine FDA Link 02/2019
1	Chymotrypsin FDA Link 01/2018
1	ixazomibIBA 01/2018
1	MLN2238IBA 01/2018
1	acceleratory factor from growth hormone (AcG)IBA 12/2017
1	osimertinibIBA 07/2017
1	Ion Channels (Ion Channel)IBA 07/2017
1	Nifedipine (Adalat)FDA LinkGeneric 11/2011
1	pyridineIBA 11/2011

Therapy/Procedure

10	Vagus Nerve Stimulation 11/2021 - 01/2020
9	Therapeutics 05/2024 - 02/2009
9	Electrodes (Electrode) 01/2024 - 08/2018
7	Deep Brain Stimulation 09/2023 - 01/2018
3	Drug Therapy (Chemotherapy) 04/2024 - 12/2019
2	Photochemotherapy (Photodynamic Therapy) 04/2024 - 04/2024
2	Radiotherapy 04/2024 - 01/2022
2	Craniotomy 08/2021 - 11/2020
2	Electrocoagulation (Electrocautery) 01/2020 - 08/2018
1	Photothermal Therapy 04/2024
1	Ligation 11/2022
1	Immunotherapy 01/2022
1	Implanted Electrodes 01/2020
1	Anterior Temporal Lobectomy 01/2018